Berkeley BioSciences, Inc. is a molecular immunology and oncology company with two divisions: biopharmaceutical and nutraceutical. It is researching and developing therapeutics and nutritional products based on patented naturally-occurring and biologically optimized phytochemicals with potent immune modulating and anti-cancer properties. The company was founded by the former Chairman of the Nutritional Sciences Department and the current Director of Cancer Research at UC Berkeley. The company's first product is ActivaMune, an immune activating nutritional product which is a fund-raiser for the company's nature-based cancer prevention and therapeutics research program. More information about ActivaMune is available at: www.ActivaMune.com.